Killing malignant mitochondria is one of the most promising approaches in the development of new anticancer drugs. Scientists from the UK have now synthesized a copper-containing peptide that is readily taken up by mitochondria in breast cancer stem cells, where it effectively induces apoptosis. The study, which has been published in the journal Angewandte Chemie, also highlights the powerful therapeutic potential of the metallopeptides.